AngioDynamics +10% premarket on FQ4 results

AngioDynamics (ANGO) Q4 results: Revenues: $96.3M (+9.1%).

Net Income: $58.9M; EPS: $1.54; Non-GAAP Net Income: $9.6M (+24.7%); Non-GAAP EPS: $0.25 (+25.0%); Quick Assets: $227.6M (+201.9%); CF Ops: $37.4M (-9.4%).

FY 2020 Guidance: Net Sales: $280M – 286M; Non-GAAP EPS: $0.25 – 0.30.

Shares are up 10% premarket.

https://seekingalpha.com/news/3476739-angiodynamics-plus-10-percent-premarket-fq4-results